MedLife Group, the leading private healthcare provider in Romania, has introduced the EarlyCDT® test, a blood-based immunologic test for the early detection of lung cancer. It identifies autoantibodies produced by the body up to 4 years before visible lesions appear. The test is non-invasive and is mainly targeted at people with risk factors, with a turnaround time of about 15 days. Studies show that the use of this test reduces late-stage diagnoses by 36%, increasing the chances of survival. MedLife reaffirms its commitment to innovation in laboratory medicine.
Sources
MedLife introduce în premieră în România testul EarlyCDT®, un test de sânge pentru depistarea timpurie a cancerului pulmonar
Inovație în medicina de laborator: MedLife introduce în premieră în România testul EarlyCDT®, un test de sânge pentru depistarea timpurie a cancerului pulmonar
MedLife introduce în premieră în România testul EarlyCDT®, un test de sânge pentru depistarea timpurie a cancerului pulmonar
Latest News
23:14
The mayor of Iași announced the cessation of street lighting at night due to the energy crisis. The measure will save approximately 10 MWh per night.
22:41
A SpaceX rocket out of control will crash on the Moon, forming a 27-meter crater.
22:01
Greece is facing new wildfires. A suburb of Athens has already been evacuated.
21:26
Traian Băsescu: Bolojan needs to rebuild the coalition with PSD for the good of the country
21:05
The Romanian Army has been mobilized to protect the operation of the Cernavodă Nuclear Power Plant, carrying out hydrographic measurements on the Danube.
See more news